CHERYL ZEIDMAN: Open Payments
NPI 1720275266 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 110 payments from 22 companies in 2025. Trend: 2023 $1,544 · 2024 $2,367 · 2025 $3,441
Food & beverage: $3,178Education: $262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $594 |
| Arcutis Biotherapeutics, Inc. | 10 | $478 |
| Janssen Biotech, Inc. | 11 | $353 |
| Galderma Laboratories, L.P. | 16 | $261 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $223 |
| Ascensia Diabetes Care US Inc. | 6 | $204 |
| PFIZER INC. | 6 | $202 |
| Novartis Pharmaceuticals Corporation | 8 | $199 |
| GENZYME CORPORATION | 7 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $127 |
Products named: Zoryve, RINVOQ, TREMFYA, SKYRIZI, CIBINQO, NEMLUVIO, DUPIXENT, SPEVIGO.
Industry payments across SC — which companies pay providers there.
